Pharmaco-disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries.

Averbuch T, Esfahani M, Khatib R, Kayima J, Miranda JJ, Wadhera RK, Zannad F, Pandey A, Van Spall HGC

Open source

DOI
10.1002/ehf2.14468
Published
2023 Oct
Container
ESC heart failure
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ehf2.14468,
  title = {Pharmaco-disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries.},
  author = {Averbuch T and Esfahani M and Khatib R and Kayima J and Miranda JJ and Wadhera RK and Zannad F and Pandey A and Van Spall HGC},
  year = {2023},
  journal = {ESC heart failure},
  doi = {10.1002/ehf2.14468},
  url = {https://doi.org/10.1002/ehf2.14468}
}

RIS

TY  - JOUR
TI  - Pharmaco-disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries.
AU  - Averbuch T
AU  - Esfahani M
AU  - Khatib R
AU  - Kayima J
AU  - Miranda JJ
AU  - Wadhera RK
AU  - Zannad F
AU  - Pandey A
AU  - Van Spall HGC
PY  - 2023
JO  - ESC heart failure
DO  - 10.1002/ehf2.14468
UR  - https://doi.org/10.1002/ehf2.14468
ER  - 

APA

T, A., M, E., R, K., J, K., JJ, M., RK, W., F, Z., A, P., & HGC, V. S. (2023). Pharmaco-disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries.. ESC heart failure. https://doi.org/10.1002/ehf2.14468

Source records